Re: The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis
- PMID: 22098960
- DOI: 10.1016/S0022-5347(11)60289-9
Re: The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis
Comment on
-
The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis.Urology. 2010 May;75(5):1138-43. doi: 10.1016/j.urology.2009.11.083. Epub 2010 Mar 19. Urology. 2010. PMID: 20303574
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical